MAY 19, 2021 9:49 PM PDT

DEA Ends the Monopoly on "Research-Grade" Cannabis

WRITTEN BY: Angela Dowden

The US Drug Enforcement Administration (DEA) has slipped out an announcement that’s going to have a huge impact on cannabis research and the development of effective medicinal cannabis products  in the United States.

“Pending final approval, DEA has determined, based on currently available information, that a number of manufacturers’ applications to cultivate marijuana for research needs in the United States appears to be consistent with applicable legal standards and relevant laws,” the statement, released May 14 2021 said.

 “DEA has, therefore, provided a Memorandum of Agreement (MOA) to these manufacturers as the next step in the approval process” it added.

The move brings to an end a decades-long monopoly on federally-approved cannabis for research purposes being grown at University of Mississippi sites. It is  a big step forward because much of this “official” cannabis has been of very poor quality and under-strength compared with the products currently on the market, making a mockery of the results from official trials, which in turn has had limited applicability to real world cannabis use.

Indeed, while it’s quite likely that the average cannabis consumer may be smoking cannabis containing 25 percent THC (the the psychoactive component), the maximum THC in the Mississippi -grown approved version has been around 8 percent. 

For researcher Dr. Sue Sisley who investigates the efficacy of medical cannabis for PTSD in veterans at the Scottsdale Research Institute, it’a a huge step forward. Her institute sued the DEA in 2019 for hindering research efforts by refusing to license new cultivators. Having finally received word from the federal agency after five years of waiting, that their application to cultivate marijuana for research needs was now moving forward, Dr. Sisley told the Wall Street Journal: “We’ve been at this so long I can’t believe we’re finally here.” 

 

Sources: Leafly, Ganjapreneur

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
JUN 21, 2021
Cannabis Sciences
Cannabis Capsule Combo Could Treat Alzheimer's
JUN 21, 2021
Cannabis Capsule Combo Could Treat Alzheimer's
Researchers led by Curtin University in Australia have developed tiny cannabidiol (CBD) capsules that could one day be u ...
AUG 18, 2021
Cannabis Sciences
Cannabis Use Disorder Linked to COVID Hospitalization
AUG 18, 2021
Cannabis Use Disorder Linked to COVID Hospitalization
People with a genetic predisposition to cannabis use disorder (CUD) are more likely to require hospitalization after con ...
OCT 14, 2021
Cannabis Sciences
Cannabis Use for Migraine Relief-New Horizons
OCT 14, 2021
Cannabis Use for Migraine Relief-New Horizons
Imagine having to leave a meeting or special occasion to go into a room, close the blinds, lie on the floor, and wait fo ...
OCT 15, 2021
Health & Medicine
Anti-seizure properties found in the Cannabinoid CBGA
OCT 15, 2021
Anti-seizure properties found in the Cannabinoid CBGA
A growing body of research suggests cannabis’s effectiveness in minimizing seizure activity, but a recent study hi ...
OCT 18, 2021
Health & Medicine
Emerging Research on Delta 8 THC
OCT 18, 2021
Emerging Research on Delta 8 THC
Delta-8-tetrahydrocannabinol is a cannabinoid derived from the hemp plant. It is one of the more prominent compounds, bu ...
NOV 23, 2021
Infographics
The Health Benefits of Cannabis
NOV 23, 2021
The Health Benefits of Cannabis
Legislation is opening more and more doors for cannabis- causing an explosion in both research and marketing campaigns f ...
Loading Comments...